Literature DB >> 2564379

T-lymphocyte subsets in patients with idiopathic dilated cardiomyopathy.

K C Huber1, B J Gersh, D D Sugrue, R L Frye, K R Bailey, R E Ritts.   

Abstract

T-cell subsets were measured in the peripheral blood of 33 patients with heart failure from idiopathic dilated cardiomyopathy, 22 patients with heart failure from other causes, and 33 normal controls. Mean T-suppressor cell percentage was 30% in normals, 21% in patients with idiopathic dilated cardiomyopathy whose duration of symptoms was less than 1 year (P = 0.0005), and 26% in those with symptoms for greater than 1 year (P = 0.05). Similarly, percentage of T-suppressor cells in the group with heart failure from causes other than idiopathic dilated cardiomyopathy was significantly lower (23%; P = 0.005) in those with short duration of symptoms. When both heart failure groups were combined those with symptoms for less than 1 year had significantly lower T-suppressor frequencies (22%) than those with symptoms for more than 1 year (P = 0.015). Multivariate analysis identified duration of symptoms and age as the only independent predictors of T-suppressor cell frequencies. Decreased percentage of T-suppressor cells in patients with idiopathic dilated cardiomyopathy may be an epiphenomenon related to duration of heart failure. This should be taken into account in assigning an etiologic mechanism for T-suppressor cells in idiopathic dilated cardiomyopathy.

Entities:  

Mesh:

Year:  1989        PMID: 2564379     DOI: 10.1016/0167-5273(89)90136-8

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Idiopathic dilated cardiomyopathy: familial prevalence and HLA distribution.

Authors:  C J McKenna; M B Codd; H A McCann; D D Sugrue
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

2.  Levels of autoantibodies against beta-adrenergic receptors and mitochondrial antigens in sera of cardiomyopathic patients estimated by ELISA method.

Authors:  T Rada; L Okruhlicová; R Monosíková; J Slezák; E Cizmárová; S Rydzi
Journal:  Basic Res Cardiol       Date:  1992 Jan-Feb       Impact factor: 17.165

3.  Protective role of ErbB3 signaling in myeloid cells during adaptation to cardiac pressure overload.

Authors:  Haifeng Yin; Amanda J Favreau-Lessard; Joanne T deKay; Yodit R Herrmann; Michael P Robich; Robert A Koza; Igor Prudovsky; Douglas B Sawyer; Sergey Ryzhov
Journal:  J Mol Cell Cardiol       Date:  2020-11-28       Impact factor: 5.000

4.  Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy.

Authors:  Kapka Miteva; Sophie Van Linthout; Hans-Dieter Volk; Carsten Tschöpe
Journal:  Stem Cells Int       Date:  2013-06-19       Impact factor: 5.443

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.